A Study to Test Safety and Tolerability of a Study Drug Called MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Patients With Moderate to Severe Atopic Dermatitis

Case Medical Research ◽

10.31525/ct1-nct03864627 ◽

2019 ◽

Author(s):

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Severe Atopic Dermatitis ◽

Topical Corticosteroids

Download Full-text

Use of Topical Corticosteroids with Tralokinumab in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.4.supp.99 ◽

2020 ◽

Vol 4 (6) ◽

pp. s99

Author(s):

Jonathan Silverberg ◽

Andrew Pink ◽

Christina Olsen ◽

Stephan Weidinger

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Severe Atopic Dermatitis ◽

Phase 3 ◽

Topical Corticosteroids

Abstract not available.

Download Full-text

Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.4.supp.102 ◽

2020 ◽

Vol 4 (6) ◽

pp. s102

Author(s):

Stephan Weidinger ◽

Jonathan Silverberg ◽

Darryl Toth ◽

Thomas Bieber ◽

Andrew Alexis ◽

...

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Severe Atopic Dermatitis ◽

Efficacy And Safety ◽

Phase 3 ◽

Topical Corticosteroids

Abstract not available.

Download Full-text

A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis

JAAD International ◽

10.1016/j.jdin.2021.11.001 ◽

2022 ◽

Vol 6 ◽

pp. 27-36

Author(s):

Norito Katoh ◽

Yukihiro Ohya ◽

Hiroyuki Murota ◽

Masanori Ikeda ◽

Xiaofei Hu ◽

...

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Blind Study ◽

Severe Atopic Dermatitis ◽

Double Blind Study ◽

Phase 3 ◽

Double Blind ◽

Topical Corticosteroids

Download Full-text

Long-term Efficacy of Tacrolimus Ointment for Recalcitrant Facial Erythema Resistant to Topical Corticosteroids in Adult Patients With Atopic Dermatitis

Archives of Dermatology ◽

10.1001/archderm.136.8.1062 ◽

2000 ◽

Vol 136 (8) ◽

pp. 1062-1063 ◽

Author(s):

H. Sugiura

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Tacrolimus Ointment ◽

Topical Corticosteroids ◽

Term Efficacy ◽

Facial Erythema

Download Full-text

Comparison of the Efficacy and Safety of 0.1% Tacrolimus Ointment with Topical Corticosteroids in Adult Patients with Atopic Dermatitis

Clinical Drug Investigation ◽

10.2165/00044011-200626050-00001 ◽

2006 ◽

Vol 26 (5) ◽

pp. 235-246 ◽

Author(s):

Hidemi Nakagawa

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Efficacy And Safety ◽

Tacrolimus Ointment ◽

Topical Corticosteroids

Download Full-text

P7 3: SAFETY AND EFFICACY OF DUPILUMAB IN ADULT PATIENTS WITH MODERATE‐TO‐SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF UP TO 100 WEEKS (LIBERTY AD OLE)

Internal Medicine Journal ◽

10.1111/imj.23_15529 ◽

2021 ◽

Vol 51 (S4) ◽

pp. 25-25

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Severe Atopic Dermatitis ◽

Safety And Efficacy

Download Full-text

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment

Acta Dermato Venereologica ◽

10.2340/00015555-3212 ◽

2019 ◽

Vol 99 (9) ◽

pp. 762-768 ◽

Author(s):

L Ariëns ◽

K Nimwegen ◽

M Shams ◽

D Bruin ◽

J Schaft ◽

...

Keyword(s):

Atopic Dermatitis ◽

Economic Burden ◽

Systemic Treatment ◽

Adult Patients ◽

Severe Atopic Dermatitis

Download Full-text

15054 Impact of baricitinib on patient-reported skin symptoms, itch, and quality of life in adult patients with moderate to severe atopic dermatitis and an inadequate response to topical therapies from phase 3 trials BREEZE-AD1 and BREEZE-AD2

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2020.06.198 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB28

Author(s):

Peter Lio ◽

Audrey Nosbaum ◽

Tracy Cardillo ◽

Amy DeLozier ◽

Margaret Gamalo ◽

...

Keyword(s):

Quality Of Life ◽

Atopic Dermatitis ◽

Adult Patients ◽

Severe Atopic Dermatitis ◽

Inadequate Response ◽

Phase 3 ◽

Skin Symptoms ◽

Patient Reported

Download Full-text

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

JAMA Dermatology ◽

10.1001/jamadermatol.2020.3260 ◽

2020 ◽

Vol 156 (12) ◽

pp. 1333 ◽

Author(s):

Kristian Reich ◽

Kenji Kabashima ◽

Ketty Peris ◽

Jonathan I. Silverberg ◽

Lawrence F. Eichenfield ◽

...

Keyword(s):

Atopic Dermatitis ◽

Severe Atopic Dermatitis ◽

Efficacy And Safety ◽

Topical Corticosteroids

Download Full-text

15260 Dupilumab treatment in adult patients with moderate to severe atopic dermatitis: A real-world single-center experience from Turkey

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2020.06.666 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB144

Author(s):

Andac Salman ◽

Meryem Aktas ◽

Esra Özkürkçü ◽

Gonca Saraç ◽

Oktay Taskapan ◽

...

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Severe Atopic Dermatitis ◽

Single Center ◽

Single Center Experience

Download Full-text